Walleye Capital
INSM icon

Walleye Capital’s Insmed INSM Stock Holding History

Walleye Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.38M Buy
26,800
+12,800
+91% +$1.97M 0.02% 887
2025
Q4 		$2.44M Buy
14,000
+800
+6% +$146K 0.01% 1723
2025
Q3 		$1.9M Buy
13,200
+10,800
+450% +$1.32M 0.01% 1618
2025
Q2 		$242K Sell
2,400
-1,000
-29% -$76.5K ﹤0.01% 3216
2025
Q1 		$259K Buy
3,400
+400
+13% +$30.6K ﹤0.01% 3067
2024
Q4 		$207K Sell
3,000
-23,200
-89% -$1.67M ﹤0.01% 3730
2024
Q3 		$1.91M Buy
+26,200
New +$1.93M ﹤0.01% 1994
2023
Q2 		– Sell
-2,700
Closed -$46K – 4570
2023
Q1 		$46K Buy
+2,700
New +$52.5K ﹤0.01% 3224
2019
Q3 		– Sell
-4,700
Closed -$120K – 2052
2019
Q2 		$120K Buy
+4,700
New +$131K 0.01% 1157

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Capital's INSM Position: Q1 2026 in Review

Walleye Capital increased its Insmed (INSM) stake by 354% in Q1 2026, buying an estimated $8.61M and bringing the position to 71,819 shares worth $11.7M. The position accounts for 0.05% of the portfolio, ranked #342.

Walleye Capital first reported a position in INSM in Q4 2021 and has held it in 15 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Walleye Capital held 71,819 shares of Insmed worth $11.7M as of Q1 2026.
  • Walleye Capital bought 55,999 Insmed shares in Q1 2026, an estimated $8.61M.
  • Insmed made up 0.05% of Walleye Capital's portfolio in Q1 2026, its #342 holding.
  • Walleye Capital first reported a position in Insmed in Q4 2021 and has held it in 15 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.